Perrigo Asthma Inhalers Recalled Due to Clog Risk
TUESDAY, Sept. 22, 2020 -- Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.
The retail recall is for all unexpired albuterol sulfate inhalation aerosol made by Catalent Pharma Solutions for Perrigo Pharmaceutical Company. The inhalers are used to treat asthma and other airway/lung conditions, such as chronic obstructive pulmonary disease. Patients should continue to use the Perrigo inhaler they have, as needed and as directed by a doctor, the FDA said.
Some of the recalled inhalers stop working after several uses. If their rescue albuterol inhaler malfunctions and does not relieve symptoms in an emergency situation, patients should immediately seek emergency care if needed, the FDA advised.
The agency recommends that patients have extra inhalers or an alternative treatment available in case of inhaler malfunction.
© 2020 HealthDay. All rights reserved.
Posted: September 2020
Read this next
WEDNESDAY, Nov. 25, 2020 -- Previous and current use of any and combined hormonal contraceptives is associated with a reduction in the risk for severe asthma exacerbation,...
WEDNESDAY, Nov. 18, 2020 -- Shift workers, especially those working permanent night shifts, have an increased risk for moderate-severe asthma and all asthma, according to a study...
WEDNESDAY, Nov. 18, 2020 -- For children with exercise-induced respiratory symptoms (EIS), diagnosis at an outpatient clinic often differs from that proposed by the referring...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.